Obamacare and health care reform might be creating a nightmare for some but...for shareholders in health information technology company Visual Healthcare (VSHC),
it's creating an opportunity to profit hand over fist.
$36 BILLION has already been earmarked for physicians and hospitals to adopt electronic health records.
Now, with federal mandates moving
into place, they have no choice but
to convert and invest in information technology systems.
With its breakthrough health care tracking technology, VSHC has come to market at the right time, making this Wall Street's Medical Technology Pick of 2011.
Health care technology is a white-hot industry—with a lot of room for investors to profit. We're not talking about advances in diagnostics or testing technology but rather advancements in information technology. Your opportunity to profit from this growing industry is right now.
Why?
Simple: the health care industry has been behind in adopting information technology to drive efficiency and cost. But now, the federal government is forcing their hand, requiring the medical community to be more accountable and their actions more traceable. That is creating incredible opportunities to profit with investments in companies that supply them with the information technology to meet new government mandates.
Visual Healthcare (VSHC) is one of those companies.
Let's cut to the chase.
What does VSHC have that could bring shareholders
rich profits in the coming days, months and years?
For starters, VSHC is a company with the information technology designed to meet and exceed new federal government demands requiring that the healthcare industry be held more accountable.
Visual Healthcare Corp. provides blueprints, tools and platforms for the coming automation of health care—Visual Health is in place with proven technology to meet demand. $36 BILLION has been earmarked for physicians and hospitals who have not already done so, to convert to electronic medical records. That's just the tip of the iceberg.
The Company's broad portfolio of proprietary technologies are a result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company.
$50 million was invested in the development of this technology process to get VSHC technology where it needs to be to meet the needs of the medical community and the federal government today and moving forward.
Specifically, VSHC designs, creates, and develops innovative platforms that help automate information in a variety of scientific disciplines, including: pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications, and quantitative analytic tools.
VSHC software allows the users to have the ability in incorporate critical medical and patient data, research real time, clinical trial data which can be tracked over time, analyzed and interactively modified in real-time, on a live database. It is the most powerful data management breakthrough, and with its extreme flexibility, is clearly set to revolutionize the health care industry.
Started in 1998, VSHC is no emerging fledgling. The company spent a decade developing this innovative technology.
Visual Healthcare with its management's unprecedented strategic foresight, is in a breakout phase within the health care industry. It is continuously growing and expanding to accommodate the demands with information overloading the system. VSHC gives the medical and pharmaceutical industry more information gathering tools and analysis than ever before—and like never before. The technology is breakthrough.
There are massive profits to be
made with a company that's
un-complicating the complicated
Consider how complex the processes are in the health care industry in our hospitals and doctor's offices alone: tracking patients, insurance, medical conditions and treatments, medications and more. It's a complex web where mistakes are costing us billions as you'll see momentarily.
VSHC platforms have a strong focus on workflow management potential saving providers millions. The company's proprietary technologies can be used in the field of medicine, hospital management, data security and health care infrastructure as well as in the pharmaceutical industry in research and development, clinical studies, chronic care monitoring and other areas.
These applications are flexible and built to conform to the way doctors and nurses provide and document patient care.
With the Health Care Reform Act about to dramatically change the medical landscape, the timing for Visual Health Care to breakout is now. Talk to your broker about buying shares in VSHC without delay.
says:
Visual Healthcare Corp. (VSHC) is "One to Watch"
Mindboggling market potential
When you consider the scope of the health care industry in the US alone, you realize just how huge Visual Healthcare (VSHC) could become. Even if VSHC infiltrated a mere portion of this market, the company could turn stunning profits and increase shareholder value many times over.
Let's look at the numbers—read that "potential customers."
Medical Facilities 10,000
Doctor's Offices and Clinics 1,326,603
Hospitals 5,795 (registered)
Physicians 954,000
# of admissions to hospitals
every year 37,120,387
This is just a small sample of the very large marketplace demonstrating the immense opportunity for VSHC.
To give you an idea of the enormity of the marketplace open to VSHC, take clinical trials. There are thousands of them taking place yet no more than 2% use information technology to drive efficiency and control costs. That's all about to change. These groups and others like them, although not early adopters of such technology, are a wide-open market segment that VSHC has just begun to tap through licensing.
Already the company's platforms are being used by more than 1000 clinicians in a dozen health care settings nationally and internationally.
Health care information technology companies are delivering sizeable profits to shareholders
Cerner Corp.: NASDAQ: CERN
Market cap: $9.36 billion
Current share price: $112.31 (as of 4/21/11)
Starting share price: $13.25 (5/90)+
Allscripts Healthcare Solutions Inc.: NASDAQ: MDRX
Market cap: $3.98 billion
Current share price: $21.04
52 week range: $15.62 -23.13
SXC Health Solutions Corp: (Toronto: SXT.TO)
Market Cap: $3.22 Billion
Current share price: $52.06
52 week range: $31.50 – 55.70
Quality Systems, Inc.: NasdaqGS: QSII
Market Cap: $ 2.6 billion
Current share price: $89.91
52 week range: $52.90-90.08
Washington is handing VSHC—and its shareholders—a license to potentially churn profits with $36 BILLION
being handed to the medical community
Obamacare may be one of the most controversial topics of our time however the quality of care at an affordable price is a driving force behind why VSHC could explode profits for investors in the coming time.
Under the American Recovery and Reinvestment Act, there are provisions to overhaul our country's health care system. Among those provisions are $36 billion earmarked for physicians and hospitals that have not yet adopted electronic health records.
Basically the government is paying the physicians/hospitals to upgrade their information technologies.
Washington has been heavy handed when it comes to the incentives built in to this bill. Apparently, the current administration has a sense of urgency for these programs to be developed and implemented quickly.
A huge government bet on technology.
Consider how VSHC's multiple information technology platforms will contribute to the success of the findings. Everything the federal government wants the health care industry to do in order to become automated and more accountable, VSHC's technology can do.
Most people won't even know who is behind that technology–except smart investors in VSHC. There has to be a measure of the quality of care and standardized data—and it's now been mandated by Washington.
Hospitals, physicians, pharmaceutical companies and others will be able to use VSHC's technology to collect, analyze, manage and develop new treatments based on hard, meaningful data collected and shared real time.
Washington launches BILLION DOLLAR INITIATIVE to prevent medical errors, delivering a pipeline of profits to VSCH
RENO, Nev., April 28, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) and its affiliated partners are poised to benefit directly from a new billion-dollar patient safety program announced Tuesday by the Obama administration.
Through this program, President Obama is challenging hospitals to dramatically cut mistakes and readmissions due to preventable errors or negligence.
To get started, the Administration is setting two ambitious goals for the next three years: Reduce preventable injuries in hospitals by 40 percent. Cut preventable hospital readmissions by 20 percent.
Those initiatives could save as much as $35 billion, including $10 billion for Medicare, according to HHS.
About $1 billion is going to be made available through the Patient Protection and Affordable Care Act in order to fund various demonstration projects over the coming three years.
According to Visual Healthcare's Gerard Dab, Chairman and CEO. "Reducing the massive incidence of drug errors in hospital can only be achieved by automation and using smart systems like ours. This program demonstrates the seriousness of the White House commitment to modernizing the healthcare industry."
VSHC built smart medical applications and quality assurance in response to the IOM...but had to wait almost a decade to see tough government policies like this one drive demand for our life saving technology.
Visual Healthcare's CPOE, Electronic Notes and Quality Assurance modules are used successfully by over one thousand clinicians and have been demonstrated to reduce both morbidity and cost associated with hospital errors by more than 30%, and fatal errors by more than 50%.
Visual Healthcare fully expects to be a part of the ADE initiative.
Here's what makes an investment in VSHC even more lucrative...the one little gem you seek for profit building
The last bastion, the health care industry is the one industry that has not embraced automation and standardization.
New legislation is reflecting a shift in public policy when it comes to healthcare information technology. Widespread deployments of IT solutions in this field are highly favored in managing growing cost and patient care.
Visual Healthcare (VSHC) expects to benefit from the shift in public policy as well as from the sizeable amount of money that will be spent in the coming years in providing patients with the best care. With the technology VSHC has provided and proven platforms already devolved and in place, it will be easy for VSHC to surge ahead (along with its shareholders) and profit from the coming changes.
Increasing shareholder value could happen very rapidly. Investing now would be wise.
What's secretly behind this push?
300,000 dead people.
Medical errors. Plain and simple.
As many as 300,000 people die each year in US hospitals from adverse drug reactions, reports Newsweek magazine. 300,000 preventable deaths. To put that in perspective, that's the equivalent of a jumbo jet crashing three times a week. As if that's not bad enough...
Another 500,000 people suffer some form of permanent injury from medical errors. In some cases the numbers are even more staggering.
Some studies have shown that up to one million medical errors occur in hospitals every year of which 50% are very serious and result in an adverse reaction. Twenty percent are potentially fatal.
Every day more than 4,000 people have an adverse drug reaction that is so serious they have to be admitted to the hospital—that's about 1.5 million hospitalizations a year. What's worse, 57% of the adverse drug reactions were not recognized by the physician when the patient was admitted.
According to the Institute of Medicine, a significant portion of medical problems in hospital settings are medication errors, resulting in adverse drug events.
Yet, the error rate can be dramatically slashed and easily averted by simply using electronic prescribing combined with decision support tools at point of care—the very technology that VSHC provides. It all comes down to better health information management.
Surely you are seeing how you could profit immensely with VSHC?
Patient safety is an ongoing struggle but health care reform is bent on reducing medical errors made by hospitals and health care facilities. VSHC has positioned itself to limit the liability of physicians and health care providers . Saving costs in malpractice and other insurances, insuring there isn't a conflict of care. VSHC early shareholders stand to capitalize within the market being first one of the first companies to address patient concerns.
Here's another reason VSHC could take off
It's not just about the errors or the people. Medical errors place a tremendous financial burden on society. In the US, the average cost of such errors has been estimated as low as $10,000 with a total annual cost of...$1 BILLION. Still, other studies have pegged that figure much higher at $100 BILLION.
According to the US Department of Health & Human Services, hospital costs annually for all adverse events (depending on facility size), are estimated to be as much as $5.6 million per hospital.
Before managed care came into play, the insurance companies would shoulder the costs. Today that cost is often absorbed by the hospitals.
Research funded by the Agency for Healthcare Research and Quality (AHRQ) shows that computerized systems can reduce medication errors and prevent adverse events. In fact, the studies indicate that anywhere from 28 to 95 percent of ADEs can be prevented.
Now, information platforms are being developed by companies such as Visual Healthcare to gather information, track critical data and analyze it a multitude of ways, preventing such errors from ever happening.
Computer Physician Order Entry (CPOE) is one of the solutions being put to use to combat medical errors—with dramatic success. Already VSHC's CPOE system is in place in 6 North American hospitals and medical facilities through VisualMED, a related company.
VSHC's technology is akin to its own wonder drug
VSHC's CPOE system spots potential errors at the earliest point in the treatment process—usually when the medication is ordered by the doctor. Instead of writing a paper prescription, the physician enters it into a computer. From there the computer checks for incorrect dosages and drugs, drug-allergy interaction, drug-drug interaction and much more.
As treatment progresses the system keeps track and monitors the treatment process, ensuring the nursing staff is administering the correct drug and dosage, issuing alerts if the patient's condition has changed and a new course of treatment should be considered. When all is said and done the information technology provides health care practitioners with the data needed to make informed decisions.
Studies have shown that technology like CPOE can reduce the incidence of errors as much as 86%. Reduction in errors leads to sizeable cost savings. VSHC is behind this dramatic reduction with its breakthrough technology.
"Research funded by the Agency for Healthcare Research and Quality (AHRQ) shows that computerized systems can reduce medication errors
and prevent adverse events. In fact, the studies indicate that anywhere from 28 to 95 percent of ADEs can be prevented."
Mistakes...at what cost?
In the late 1990s, the Institute of Medicine issues issued a sobering report on the cost and causes of adverse drug events. The Institute concluded that the solution to preventing medical errors is "building a safer health system" that leads health care providers down the appropriate paths of treatment and limits their ability to make mistakes.
Some of the highlights from their research are shocking, making it easy to see why information platforms such as those that VSHC brings to the table are going to meet with resounding success.
•Patients who experienced adverse drug events (ADEs) were hospitalized an average of 8 to 12 days longer than patients who did not suffer ADEs, and their hospitalization cost $16,000 to $24,000 more.
•Anywhere from 28 percent to 95 percent of ADEs can be prevented by reducing medication errors through computerized monitoring systems.
•Computerized medication order entry has the potential to prevent an estimated 84 percent of dose, frequency, and route errors.
•Small Hospitals can save as much as $1,500,000, large regional institutions $20,000,000 annually in direct costs by using computerized systems.
VSHC platforms reduce direct and ancillary costs as well as insurance premiums and increase patient flow-through.
As hospitals, medical centers and other health care facilities continue to add technology to address this problem and similar information issues, VSHC is expected to continue to soar. Your investment today for just pennies on the dollar could be one of the most profitable ones you'll ever make. You are urged to talk to your broker without delay.
How does VSHC make money?
The Company licenses their technology to operating companies and, in exchange, Visual Health Care takes an equity stake or royalty stream. VSHC also owns a substantial stake in medical software company VisualMED Clinical Solutions Corp. VisualMED is a leader in the field of electronic health records.
Additional technology platforms are changing the
health care industry—and creating MORE revenue
streams for VSHC
VSHC has multiple proprietary platforms for research and development in the pharmaceutical industry. The showcase of this platform is its ability to analyze data to a depth of 49 levels and it's powered by more than 33,000 decisional algorithms.
Visual Healthcare is the sole owner of all intellectual property rights to this platform and all others as well as the inference engines, software, modules and applications they have developed over the years.
Take a look at what some of these platforms can do for the pharmaceutical industry:
In clinical trials the platform acts as a centralized information management center. It provides decision support technology for cohort analysis and identification while allowing for real-time communication and instant input recognition across the entire database.
When it comes to insurance management, the platform increases the data pool for results-powered risk assessment and increases quality assurance for key factor identification and effective model distribution.
Epidemiology & Disease Control has the benefit of a disease registry that can track the progress of diseases—and establish origination patterns based on proprietary data mining techniques. In essence, the registry collects, manages and analyzes data about specific cases and deaths.
VSHC's registry is a dynamic, sought-after tool for monitoring trends, pinpointing patterns in populations, guiding the planning and evaluation of controls programs, advancing clinical, epidemiologic, and health services research, assisting practitioners in reporting suspected increases in occurrence and more.
This is a true breakthrough in research and development in the pharmaceutical industry.
Get ready to potentially roll in the profits because there is
so much more to VSHC's breakthrough technology
It's important for you to know, if you are considering an investment, the depths of information technology VSHC has developed and is developing—and what it means to the health care and pharmaceutical industries.
Beyond what you have already read, VSHC is also developing new software that allows physicians to reduce the cost of following patients suffering from chronic conditions. Recent studies show that treatment of chronic illness may constitute up to three quarters of healthcare budgets.
With US health care costs out of sight, and the need to contain the costs a critical need, this type of efficiency application is already in demand. Elimination of duplication and better home care monitoring are just two benefits.
Using Homecare Monitoring, VSHC's platforms can monitor patients at a distance and give care teams the ability to keep tabs on patients who require constant supervision—particularly those with chronic illnesses—where patients can be treated at home.
Homecare Monitoring dispenses of the unnecessary burden on a facility where a patient might normally be treated on an in-patient basis, or even have to bear the cost of hospitalization.
There's so much more that VSHC's technology can do. You can learn more at www.visualhealthcare.com
Visual Healthcare breaks new ground in pharmaceutical industry
“Most physicians find it difficult to go through 10,000 files in order to find qualified patients, and often miss this important revenue source. By storing patient data on one of our smart platforms, a physician will be able to establish a complete list in less than a day, which will make a positive contribution to his bottom line.”
-- Gerard Dab, Chairman and CEO, Visual HealthcareVisual Healthcare Corp. announced that they are breaking new ground in providing the pharmaceutical industry with highly flexible and secure tools for gathering clinical data from multiple sources worldwide for research purposes.
They have combined their smart inference engine with clinical-specific capture tools to gather physicians' data concerning patients registered in clinical research cohorts.
Moreover, these tools have special analytics that make it extremely time-effective for physicians to qualify patients for participating in such research.
Gerard Dab, Chairman and CEO, says, "Most physicians find it difficult to go through 10,000 files in order to find qualified patients, and often miss this important revenue source. By storing patient data on one of our smart platforms, a physician will be able to establish a complete list in less than a day, which will make a positive contribution to his bottom line."
Mega-money buyout could be imminent
Visual Healthcare is growing and it's setting itself apart from the competition with its innovation—in a big way. Take, for example, Siemens, IBM, Kaiser Permanente, Oracle, Microsoft and Google. They've all tried to create smart automation—and failed.
It is estimated that IBM spent $5 billion...Siemens $2 billion...GE $2-3 billion...Kaiser $5 billion. Siemens system has yet to be fully implemented commercially anywhere in the world.
Knowing how much more advanced VSHC's technology platforms are—and seeing the big money buyouts that have taken place—there is strong potential for Visual Healthcare (VSHC) to be bought by a major soon.
Look at some of the big money acquisitions that have taken place:
•GE Healthcare—the $17 billion medical technology and services subsidiary of General Electric— bought IDX Systems Corp., a provider of healthcare information technology, for $1.2 billion.
•GE Healthcare acquired MedPlexus, Inc., for an undisclosed amount. MedPlexus sells electronic health records, revenue-cycle management software, and hosted services for payroll and billing to small, independent practices.
•McKesson Corp. bought System C Healthcare for $139.9 million in cash. System C is known for its Medway suite of clinical and care management systems in use across 40 hospitals and by the private sector.
•Aetna, Inc. acquired Medicity, a company with a medical data exchange platform for $500 million.
•Ingenix/UnitedHealth acquired Axolotl Corp., a health-data network for an undisclosed amount.
With its proprietary information technology platform and revolutionary software, VSHC's technology clearly outperforms the competition and a deal with a major could be bigger than any of these deals.
